Skip to main content
. 2017 Jul 6;12(7):e0180417. doi: 10.1371/journal.pone.0180417

Fig 3. DGBX regulates the proliferation of CD3+CD4+ T cells in PBs and splenocytes.

Fig 3

(A) The percentages of CD3+CD4+ T cells in PBs of mice after 4 weeks of treatment. (B) The percentages of CD3+CD4+ T cells in splenocytes of mice after 4 weeks of treatment. The results are presented in the bar charts; a. normal group, b. model group, c. group treated with CsA, and d. group treated with DGBX. The data are presented as means ± SD, n = 6. *P<0.05, **P < 0.01.